Market Research Logo

Melinta Therapeutics Inc - Strategic SWOT Analysis Review

Melinta Therapeutics Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for serious skin infections known as acute bacterial skin and skin structure infections (ABSSSI). Delafloxacin is also being as an investigational antibiotic for Serious Community-Acquired Bacterial Pneumonia (CABP) and Complicated Urinary Tract Infections (cUTI). It also has multiple Oxazolidinone and Macrolide Programs in Pre-clinical and Clinical studies. The products are based on its ribosome crystallography platform, engineered to overcome the problem of drug resistance. The company has partnerships with Menarini Group; Malin Plc; Eurofarma Laboratorios for the commercialization of its products. Melinta is headquartered at New Haven, Connecticut, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company 5
Melinta Therapeutics Inc - Key Facts 5
Melinta Therapeutics Inc - Key Employees 6
Melinta Therapeutics Inc - Key Employee Biographies 7
Melinta Therapeutics Inc - Major Products and Services 8
Melinta Therapeutics Inc - History 9
Melinta Therapeutics Inc - Company Statement 10
Melinta Therapeutics Inc - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Melinta Therapeutics Inc - Business Description 12
Melinta Therapeutics Inc - Corporate Strategy 13
Melinta Therapeutics Inc - SWOT Analysis 14
SWOT Analysis - Overview 14
Melinta Therapeutics Inc - Strengths 14
Melinta Therapeutics Inc - Weaknesses 15
Melinta Therapeutics Inc - Opportunities 16
Melinta Therapeutics Inc - Threats 17
Melinta Therapeutics Inc - Key Competitors 18
Section 3 – Company’s Lifesciences Financial Deals and Alliances 19
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20
Melinta Therapeutics Inc, Recent Deals Summary 21
Section 4 – Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Melinta Therapeutics Inc, Key Facts 5
Melinta Therapeutics Inc, Key Employees 6
Melinta Therapeutics Inc, Key Employee Biographies 7
Melinta Therapeutics Inc, Major Products and Services 8
Melinta Therapeutics Inc, History 9
Melinta Therapeutics Inc, Other Locations 11
Melinta Therapeutics Inc, Key Competitors 18
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 20
Melinta Therapeutics Inc, Recent Deals Summary 21
List of Figures
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 19
Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 20

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report